AbbVie will commit less capital towards experimental medicines for psychiatric disease, CEO Robert Michael said at an ...
AbbVie will write off $3.5 billion related to its $8.7 billion investment in Cerevel Therapeutics following the failure of the company's key schizophrenia drug, emraclidine, The Wall Street Journal ...
But many people who take daily medications are unaware that certain drugs in their pill box can also increase their risk of ...
A 67-year-old Lincoln man was charged Friday after an undercover police investigation discovered drugs ranging from marijuana to amphetamine pills and six guns, according to court records.
A former South Charleston psychiatrist was sentenced to three years incarceration by a federal judge Wednesday, Jan. 8, 2025, ...